{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T18:07:45Z","timestamp":1794679665516,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67867-2","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T04:33:56Z","timestamp":1766464436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["IL-33 expands plasma cells, disrupts germinal centers, and increases autoantibody production in mice"],"prefix":"10.1038","volume":"17","author":[{"given":"Eva","family":"Conde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seblewongel","family":"Asrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vecchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Gayvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Pedraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carley","family":"Tasker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Yarilin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Birchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hong","family":"Ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-2570","authenticated-orcid":false,"given":"Wei Keat","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Sleeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9052-0146","authenticated-orcid":false,"given":"Andre","family":"Limnander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2695-6508","authenticated-orcid":false,"given":"Jamie M.","family":"Orengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"67867_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479\u2013490 (2005).","journal-title":"Immunity"},{"key":"67867_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol, C. & Girard, J. P. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family. Immunol. Rev. 281, 154\u2013168 (2018).","journal-title":"Immunol. Rev."},{"key":"67867_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","volume":"8","author":"B Griesenauer","year":"2017","unstructured":"Griesenauer, B. & Paczesny, S. The ST2\/IL-33 axis in immune cells during inflammatory diseases. Front. Immunol. 8, 475 (2017).","journal-title":"Front. Immunol."},{"key":"67867_CR4","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.jaci.2019.08.039","volume":"144","author":"J Allinne","year":"2019","unstructured":"Allinne, J. et al. IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation. J. Allergy Clin. Immunol. 144, 1624\u20131637 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"67867_CR5","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S2213-2600(21)00167-3","volume":"9","author":"KF Rabe","year":"2021","unstructured":"Rabe, K. F. et al. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial. Lancet Respi Me 9, 1288\u20131298 (2021).","journal-title":"Lancet Respi Me"},{"key":"67867_CR6","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","volume":"385","author":"ME Wechsler","year":"2021","unstructured":"Wechsler, M. E. et al. Efficacy and safety of Itepekimab in patients with moderate-to-severe asthma. N. Engl. J. Med. 385, 1656\u20131668 (2021).","journal-title":"N. Engl. J. Med."},{"key":"67867_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","volume":"382","author":"M Wahren-Herlenius","year":"2013","unstructured":"Wahren-Herlenius, M. & Dorner, T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 382, 819\u2013831 (2013).","journal-title":"Lancet"},{"key":"67867_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/0192623311428481","volume":"40","author":"B Bolon","year":"2012","unstructured":"Bolon, B. Cellular and molecular mechanisms of autoimmune disease. Toxicol. Pathol. 40, 216\u2013229 (2012).","journal-title":"Toxicol. Pathol."},{"key":"67867_CR9","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/art.34449","volume":"64","author":"HS El-Gabalawy","year":"2012","unstructured":"El-Gabalawy, H. S. et al. Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients. Arthritis Rheumatol. 64, 1720\u20131729 (2012).","journal-title":"Arthritis Rheumatol."},{"key":"67867_CR10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1006\/bbrc.2001.5090","volume":"284","author":"K Kuroiwa","year":"2001","unstructured":"Kuroiwa, K., Arai, T., Okazaki, H., Minota, S. & Tominaga, S. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem. Biophys. Res. Commun. 284, 1104\u20131108 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"67867_CR11","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.3389\/fimmu.2018.02871","volume":"9","author":"WA Rose","year":"2018","unstructured":"Rose, W. A. et al. Interleukin-33 contributes toward loss of tolerance by promoting B-cell-activating factor of the tumor-necrosis-factor family (BAFF)-dependent autoantibody production. Front. Immunol. 9, 2871 (2018).","journal-title":"Front. Immunol."},{"key":"67867_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s11095-010-0338-9","volume":"28","author":"B Bonamassa","year":"2011","unstructured":"Bonamassa, B., Hai, L. & Liu, D. Hydrodynamic gene delivery and its applications in pharmaceutical research. Pharm. Res. 28, 694\u2013701 (2011).","journal-title":"Pharm. Res."},{"key":"67867_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1398-9995.2012.02859.x","volume":"67","author":"M Komai-Koma","year":"2012","unstructured":"Komai-Koma, M. et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice. Allergy 67, 1118\u20131126 (2012).","journal-title":"Allergy"},{"key":"67867_CR14","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/nri3300","volume":"12","author":"C Benoist","year":"2012","unstructured":"Benoist, C., Lanier, L., Merad, M., Mathis, D. & Immunological Genome, P. Consortium biology in immunology: the perspective from the Immunological Genome Project. Nat. Rev. Immunol. 12, 734\u2013740 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"67867_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1084\/jem.151.5.1071","volume":"151","author":"LA Herzenberg","year":"1980","unstructured":"Herzenberg, L. A., Black, S. J., Tokuhisa, T. & Herzenberg, L. A. Memory B cells at successive stages of differentiation. Affinity maturation and the role of IgD receptors. J. Exp. Med. 151, 1071\u20131087 (1980).","journal-title":"J. Exp. Med."},{"key":"67867_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-1759(97)00143-9","volume":"209","author":"R Craston","year":"1997","unstructured":"Craston, R. et al. Temporal dynamics of CD69 expression on lymphoid cells. J. Immunol. Methods 209, 37\u201345 (1997).","journal-title":"J. Immunol. Methods"},{"key":"67867_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2567.2006.02382.x","volume":"118","author":"K Horikawa","year":"2006","unstructured":"Horikawa, K. & Takatsu, K. Interleukin-5 regulates genes involved in B-cell terminal maturation. Immunology 118, 497\u2013508 (2006).","journal-title":"Immunology"},{"key":"67867_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/BF02919733","volume":"10","author":"GR Harriman","year":"1991","unstructured":"Harriman, G. R., Allison, K. C. & Strober, W. Expression of IL-5 receptors on B cells: role in mucosal B cell responses. Immunol. Res. 10, 413\u2013417 (1991).","journal-title":"Immunol. Res."},{"key":"67867_CR19","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/382462a0","volume":"382","author":"M Matsumoto","year":"1996","unstructured":"Matsumoto, M. et al. Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice. Nature 382, 462\u2013466 (1996).","journal-title":"Nature"},{"key":"67867_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1084\/jem.20042060","volume":"201","author":"EJ Blink","year":"2005","unstructured":"Blink, E. J. et al. Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J. Exp. Med. 201, 545\u2013554 (2005).","journal-title":"J. Exp. Med."},{"key":"67867_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","volume":"28","author":"K Yanaba","year":"2008","unstructured":"Yanaba, K. et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28, 639\u2013650 (2008).","journal-title":"Immunity"},{"key":"67867_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/imr.12741","volume":"288","author":"SA Jenks","year":"2019","unstructured":"Jenks, S. A., Cashman, K. S., Woodruff, M. C., Lee, F. E. & Sanz, I. Extrafollicular responses in humans and SLE. Immunol. Rev. 288, 136\u2013148 (2019).","journal-title":"Immunol. Rev."},{"key":"67867_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","volume":"45","author":"L Mesin","year":"2016","unstructured":"Mesin, L., Ersching, J. & Victora, G. D. Germinal Center B Cell Dynamics. Immunity 45, 471\u2013482 (2016).","journal-title":"Immunity"},{"key":"67867_CR24","doi-asserted-by":"publisher","first-page":"E2567","DOI":"10.1073\/pnas.1406974111","volume":"111","author":"Z Sabouri","year":"2014","unstructured":"Sabouri, Z. et al. Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity. Proc. Natl. Acad. Sci. USA 111, E2567\u2013E2575 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67867_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/197197a0","volume":"197","author":"BJ Helyer","year":"1963","unstructured":"Helyer, B. J. & Howie, J. B. Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature 197, 197 (1963).","journal-title":"Nature"},{"key":"67867_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","volume":"42","author":"AB Molofsky","year":"2015","unstructured":"Molofsky, A. B., Savage, A. K. & Locksley, R. M. Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity 42, 1005\u20131019 (2015).","journal-title":"Immunity"},{"key":"67867_CR27","doi-asserted-by":"publisher","unstructured":"Singh, D. et al. A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4. Eur. Respir. J. 66, https:\/\/doi.org\/10.1183\/13993003.02231-2024 (2025).","DOI":"10.1183\/13993003.02231-2024"},{"key":"67867_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","volume":"31","author":"C Cayrol","year":"2014","unstructured":"Cayrol, C. & Girard, J. P. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr. Opin. Immunol. 31, 31\u201337 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"67867_CR29","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.4049\/jimmunol.1003383","volume":"186","author":"M Enoksson","year":"2011","unstructured":"Enoksson, M. et al. Mast cells as sensors of cell injury through IL-33 recognition. J. Immunol. 186, 2523\u20132528 (2011).","journal-title":"J. Immunol."},{"key":"67867_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1034\/j.1600-065X.2003.00058.x","volume":"194","author":"IC MacLennan","year":"2003","unstructured":"MacLennan, I. C. et al. Extrafollicular antibody responses. Immunol. Re.v 194, 8\u201318 (2003).","journal-title":"Immunol. Re.v"},{"key":"67867_CR31","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1084\/jem.20061254","volume":"203","author":"TG Phan","year":"2006","unstructured":"Phan, T. G. et al. High affinity germinal center B cells are actively selected into the plasma cell compartment. J. Exp. Med. 203, 2419\u20132424 (2006).","journal-title":"J. Exp. Med."},{"key":"67867_CR32","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cell.2020.09.063","volume":"183","author":"C Viant","year":"2020","unstructured":"Viant, C. et al. Antibody affinity shapes the choice between memory and germinal center B cell fates. Cell 183, 1298\u20131311 (2020).","journal-title":"Cell"},{"key":"67867_CR33","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.immuni.2020.11.006","volume":"53","author":"RA Elsner","year":"2020","unstructured":"Elsner, R. A. & Shlomchik, M. J. Germinal center and extrafollicular B cell responses in vaccination, immunity, and autoimmunity. Immunity 53, 1136\u20131150 (2020).","journal-title":"Immunity"},{"key":"67867_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1084\/jem.20091738","volume":"207","author":"MA Linterman","year":"2010","unstructured":"Linterman, M. A. et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207, 353\u2013363 (2010).","journal-title":"J. Exp. Med."},{"key":"67867_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","volume":"183","author":"N Kaneko","year":"2020","unstructured":"Kaneko, N. et al. Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell 183, 143\u2013157 (2020).","journal-title":"Cell"},{"key":"67867_CR36","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1128\/IAI.00372-08","volume":"76","author":"ET Cadman","year":"2008","unstructured":"Cadman, E. T. et al. Alterations of splenic architecture in malaria are induced independently of Toll-like receptors 2, 4, and 9 or MyD88 and may affect antibody affinity. Infect. Immun. 76, 3924\u20133931 (2008).","journal-title":"Infect. Immun."},{"key":"67867_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.celrep.2015.12.006","volume":"14","author":"V Ryg-Cornejo","year":"2016","unstructured":"Ryg-Cornejo, V. et al. Severe Malaria infections impair germinal center responses by inhibiting T follicular helper cell differentiation. Cell Rep. 14, 68\u201381 (2016).","journal-title":"Cell Rep."},{"key":"67867_CR38","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1128\/IAI.00333-12","volume":"80","author":"A Glatman Zaretsky","year":"2012","unstructured":"Glatman Zaretsky, A. et al. Infection with Toxoplasma gondii alters lymphotoxin expression associated with changes in splenic architecture. Infect. Immun. 80, 3602\u20133610 (2012).","journal-title":"Infect. Immun."},{"key":"67867_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.749569","volume":"8","author":"SS Markovic","year":"2021","unstructured":"Markovic, S. S. et al. IL 33 Correlates with COVID-19 severity, radiographic and clinical finding. Front. Med. 8, 749569 (2021).","journal-title":"Front. Med."},{"key":"67867_CR40","doi-asserted-by":"publisher","unstructured":"Lewis, S. M., Williams, A. & Eisenbarth, S. C. Structure and function of the immune system in the spleen. Sci. Immunol. 4, https:\/\/doi.org\/10.1126\/sciimmunol.aau6085 (2019).","DOI":"10.1126\/sciimmunol.aau6085"},{"key":"67867_CR41","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1084\/jem.189.11.1799","volume":"189","author":"L Mandik-Nayak","year":"1999","unstructured":"Mandik-Nayak, L. et al. MRL-lpr\/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med. 189, 1799\u20131814 (1999).","journal-title":"J. Exp. Med."},{"key":"67867_CR42","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks, S. A. et al. Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725\u2013739 (2018).","journal-title":"Immunity"},{"key":"67867_CR43","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1073\/pnas.0912678107","volume":"107","author":"L Pastorelli","year":"2010","unstructured":"Pastorelli, L. et al. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1\/Th2 driven enteritis. Proc. Natl. Acad. Sci. USA 107, 8017\u20138022 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67867_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semarthrit.2015.02.001","volume":"45","author":"J Shen","year":"2015","unstructured":"Shen, J. et al. IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study. Semin. Arthritis Rheum. 45, 18\u201327 (2015).","journal-title":"Semin. Arthritis Rheum."},{"key":"67867_CR45","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/art.24305","volume":"60","author":"G Palmer","year":"2009","unstructured":"Palmer, G. et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum. 60, 738\u2013749 (2009).","journal-title":"Arthritis Rheum."},{"key":"67867_CR46","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3899\/jrheum.100184","volume":"37","author":"R Mu","year":"2010","unstructured":"Mu, R. et al. Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis. J. Rheumatol. 37, 2006\u20132013 (2010).","journal-title":"J. Rheumatol."},{"key":"67867_CR47","first-page":"897","volume":"40","author":"A Moreau","year":"2022","unstructured":"Moreau, A., Nicaise, C., Awada, A. & Soyfoo, M. S. Soluble ST2 is increased in systemic lupus erythematous and is a potential marker of lupus nephritis. Clin. Exp. Rheumatol. 40, 897\u2013903 (2022).","journal-title":"Clin. Exp. Rheumatol."},{"key":"67867_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10238-010-0115-4","volume":"11","author":"Z Yang","year":"2011","unstructured":"Yang, Z., Liang, Y., Xi, W., Li, C. & Zhong, R. Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population. Clin. Exp. Med. 11, 75\u201380 (2011).","journal-title":"Clin. Exp. Med."},{"key":"67867_CR49","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s10753-013-9802-0","volume":"37","author":"P Li","year":"2014","unstructured":"Li, P., Lin, W. & Zheng, X. IL-33 neutralization suppresses lupus disease in lupus-prone mice. Inflammation 37, 824\u2013832 (2014).","journal-title":"Inflammation"},{"key":"67867_CR50","doi-asserted-by":"publisher","unstructured":"Georgakis, S. et al. NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-alpha production in patients with SLE. JCI Insight 6, https:\/\/doi.org\/10.1172\/jci.insight.147671 (2021).","DOI":"10.1172\/jci.insight.147671"},{"key":"67867_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11926-016-0562-3","volume":"18","author":"D Fernandez","year":"2016","unstructured":"Fernandez, D. & Kirou, K. A. What Causes Lupus Flares? Curr. Rheumatol. Rep. 18, 14 (2016).","journal-title":"Curr. Rheumatol. Rep."},{"key":"67867_CR52","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1164\/rccm.200701-014OC","volume":"177","author":"CA Feghali-Bostwick","year":"2008","unstructured":"Feghali-Bostwick, C. A. et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177, 156\u2013163 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"67867_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.imlet.2019.08.007","volume":"214","author":"R Byrne","year":"2019","unstructured":"Byrne, R., Todd, I., Tighe, P. J. & Fairclough, L. C. Autoantibodies in chronic obstructive pulmonary disease: A systematic review. Immunol. Lett. 214, 8\u201315 (2019).","journal-title":"Immunol. Lett."},{"key":"67867_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3899\/jrheum.090492","volume":"37","author":"Y Matsuyama","year":"2010","unstructured":"Matsuyama, Y. et al. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J. Rheumatol. 37, 18\u201325 (2010).","journal-title":"J. Rheumatol."},{"key":"67867_CR55","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/sj.gt.3300947","volume":"6","author":"F Liu","year":"1999","unstructured":"Liu, F., Song, Y. & Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6, 1258\u20131266 (1999).","journal-title":"Gene Ther."},{"key":"67867_CR56","doi-asserted-by":"publisher","first-page":"19509","DOI":"10.1073\/pnas.0905669106","volume":"106","author":"R Thomson","year":"2009","unstructured":"Thomson, R., Molina-Portela, P., Mott, H., Carrington, M. & Raper, J. Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes. Proc. Natl. Acad. Sci. USA 106, 19509\u201319514 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67867_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/srep23204","volume":"6","author":"A Atanasio","year":"2016","unstructured":"Atanasio, A. et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci. Rep. 6, 23204 (2016).","journal-title":"Sci. Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67867-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67867-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67867-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:04:34Z","timestamp":1769612674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67867-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67867"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67867-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was sponsored by Regeneron Pharmaceuticals, Inc. All authors are current or former employees of Regeneron and may hold stock options in the company. A.J.M. and J.M.O. are officers of Regeneron Pharmaceuticals. J.M.O. and A.J.M. are inventors on published patents related to this work (9453072 and 9637535).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1102"}}